The Atracurium Besylate Injection, cataloged under National Stock Number 6505-01-215-7755, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-215-7755 |
| Primary Part Number | NDC25021-0672-10 |
| Item Name | Atracurium Besylate Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 10.000 MILLILITERS |
| Primary Container Type | VIAL |
| Protective Storage Feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| Active Medicament Medicinal Strength | 10.000 MILLIGRAMS ATRACURIUM BESYLATE PER MILLILITER |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC25021-0672-10 PRIMARY | Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00409-1105-02 | 5/9 Secondary reference Hospira, Inc. |
NSN 6505-01-215-7755 is a Atracurium Besylate Injection, manufactured by Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-215-7755 has 1 manufacturer part number on file: NDC25021-0672-10 (Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc).
Key specifications for NDC25021-0672-10: Primary Container Content Quantity: 10.000 MILLILITERS; Primary Container Type: VIAL; Special Features: MULTIDOSE VIALS; Protective Storage Feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.